WallStSmart
ANIX

Anixa Biosciences Inc

NASDAQ: ANIX · HEALTHCARE · BIOTECHNOLOGY

$3.00
+4.17% today

Updated 2026-04-30

Market cap
$102.26M
P/E ratio
P/S ratio
377.78x
EPS (TTM)
$-0.32
Dividend yield
52W range
$2 – $5
Volume
0.1M

Anixa Biosciences Inc (ANIX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$508651.00$486852.00$2.06M$1.06M$730675.00$1.00M$940010.00$388850.00$3.67M$9.26M$300000.00$362500.00$1.11M$250000.00$0.00$512000.00$2.47B$210000.00$0.00$0.00
Revenue growth (YoY)-4.3%+323.8%-48.8%-30.8%+37.3%-6.3%-58.6%+843.1%+152.4%-96.8%+20.8%+206.9%-77.5%-100.0%+482126.6%-100.0%-100.0%
Cost of revenue$156446.00$160360.00$95594.00$65688.00$82307.00$34081.00$3873.00$316658.00$1.99M$3.65M$217416.00$104556.00$1.09M$166250.00$90157.00$385000.00$42000.00$161000.00$37000.00$36000.00
Gross profit$352205.00$326492.00$1.97M$990109.00$648368.00$969112.00$940010.00$72192.00$1.68M$5.61M$82584.00$257944.00$18794.00$83750.00$-90157.00$127000.00$2.47B$49000.00$-37000.00$-36000.00
Gross margin69.2%67.1%95.4%93.8%88.7%96.6%100.0%18.6%45.8%60.6%27.5%71.2%1.7%33.5%24.8%100.0%23.3%
R&D$4.61M$3.40M$4.13M$4.12M$3.01M$3.12M$2.21M$1.19M$711391.00$1.56M$1.60M$6.81M$5.47M$4.38M$6.19M$6.70M$4.77M$6.40M$5.07M
SG&A$3.37M$2.41M$3.83M$4.19M$2.89M$2.87M$2.86M$7.99M$6.41M$5.51M$2.71M$4.41M$6.91M$5.66M$5.60M$7.07M$7.17M$6.29M$7.43M$6.63M
Operating income$-7.63M$-5.49M$-5.99M$-7.32M$-5.25M$-5.03M$-4.13M$-7.92M$-5.04M$-944759.00$-4.51M$-6.08M$-13.71M$-11.89M$-9.98M$-13.14M$-13.88M$-11.01M$-13.83M$-11.70M
Operating margin-1499.6%-1128.1%-290.3%-693.3%-718.3%-501.2%-439.8%-2036.2%-137.5%-10.2%-1503.0%-1676.0%-1232.0%-4756.0%-2565.6%-0.6%-5243.3%
EBITDA$-7.61M$-5.45M$-5.98M$-7.32M$-5.25M$-6.77M$-4.24M$-8.97M$-8.03M$-601846.00$-4.14M$-4.14M$-13.90M$-11.00M$-10.00M$-13.08M$-13.73M$-10.96M$-12.66M$-11.70M
EBITDA margin-1496.6%-1119.1%-289.8%-693.3%-718.3%-674.9%-450.8%-2306.9%-218.9%-6.5%-1379.3%-1142.1%-1249.4%-4402.0%-2554.9%-0.6%-5221.4%
EBIT$-7.63M$-5.46M$-5.99M$-7.33M$-5.26M$-6.78M$-4.25M$-8.97M$-8.34M$-939652.00$-4.50M$-4.51M$-14.24M$-11.47M$-10.09M$-13.14M$-13.77M$-11.01M$-12.70M$-11.74M
Interest expense$0.00$0.00$0.00$0.00$0.00$3.50M$7664.00$1.11M$1.26M$451906.00$519946.00$500455.00$0.00$0.00$33923.00$322.00$104000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-7.60M$-5.46M$-5.82M$-16.49M$-5.18M$-7.38M$-4.25M$-10.08M$-9.61M$-1.38M$-5.02M$-5.01M$-14.00M$-11.65M$-10.13M$-12.95M$-13.60M$-9.81M$-12.55M$-10.93M
Net income growth (YoY)+28.2%-6.7%-183.2%+68.6%-42.6%+42.4%-137.0%+4.7%+85.6%-263.8%+0.1%-179.4%+16.8%+13.0%-27.8%-5.0%+27.8%-28.0%+13.0%
Profit margin-1494.3%-1121.1%-282.2%-1561.8%-708.3%-735.5%-452.4%-2592.3%-261.9%-14.9%-1672.1%-1381.8%-1258.1%-4658.8%-2528.6%-0.6%-4671.9%